These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9118104)

  • 1. Antagonism of endotoxin-induced disruption of equine bowel motility by flunixin and phenylbutazone.
    King JN; Gerring EL
    Equine Vet J Suppl; 1989 Jun; (7):38-42. PubMed ID: 9118104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The action of low dose endotoxin on equine bowel motility.
    King JN; Gerring EL
    Equine Vet J; 1991 Jan; 23(1):11-7. PubMed ID: 2015801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of flunixin meglumine and meloxicam for post operative management of horses with strangulating small intestinal lesions.
    Naylor RJ; Taylor AH; Knowles EJ; Wilford S; Linnenkohl W; Mair TS; Johns IC
    Equine Vet J; 2014 Jul; 46(4):427-34. PubMed ID: 24372991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of detomidine, butorphanol, flunixin meglumine and xylazine in clinical cases of equine colic.
    Jochle W; Moore JN; Brown J; Baker GJ; Lowe JE; Fubini S; Reeves MJ; Watkins JP; White NA
    Equine Vet J Suppl; 1989 Jun; (7):111-6. PubMed ID: 9118091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre, blinded, randomised clinical trial comparing the use of flunixin meglumine with firocoxib in horses with small intestinal strangulating obstruction.
    Ziegler AL; Freeman CK; Fogle CA; Burke MJ; Davis JL; Cook VL; Southwood LL; Blikslager AT
    Equine Vet J; 2019 May; 51(3):329-335. PubMed ID: 30156312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of endotoxin-induced disruption of equine gastrointestinal motility with the platelet-activating factor antagonist WEB 2086.
    King JN; Gerring EL
    J Vet Pharmacol Ther; 1990 Dec; 13(4):333-9. PubMed ID: 2287025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisapride in the prophylaxis of equine post operative ileus.
    Gerring EL; King JN
    Equine Vet J Suppl; 1989 Jun; (7):52-5. PubMed ID: 9118107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B.
    Bryant CE; Farnfield BA; Janicke HJ
    Am J Vet Res; 2003 Feb; 64(2):211-5. PubMed ID: 12602591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of single-dose intravenous phenylbutazone and flunixin meglumine before, during and after exercise in an experimental reversible model of foot lameness in horses.
    Foreman JH; Grubb TL; Inoue OJ; Banner SE; Ball KT
    Equine Vet J Suppl; 2010 Nov; (38):601-5. PubMed ID: 21059067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental uses of flunixin meglumine and phenylbutazone in food-producing animals.
    Kopcha M; Ahl AS
    J Am Vet Med Assoc; 1989 Jan; 194(1):45-9. PubMed ID: 2644181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses.
    Reed SK; Messer NT; Tessman RK; Keegan KG
    Am J Vet Res; 2006 Mar; 67(3):398-402. PubMed ID: 16506899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome.
    Erkert RS; MacAllister CG; Payton ME; Clarke CR
    Am J Vet Res; 2005 Feb; 66(2):284-8. PubMed ID: 15757129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.
    Beretta C; Garavaglia G; Cavalli M
    Pharmacol Res; 2005 Oct; 52(4):302-6. PubMed ID: 15939622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of slow infusion of a low dosage of endotoxin in healthy horses.
    Clark ES; Moore JN
    Equine Vet J Suppl; 1989 Jun; (7):33-7. PubMed ID: 9118103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative analgesia using phenylbutazone, flunixin or carprofen in horses.
    Johnson CB; Taylor PM; Young SS; Brearley JC
    Vet Rec; 1993 Oct; 133(14):336-8. PubMed ID: 8236675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):172-9. PubMed ID: 6883184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin.
    Lees P; Ewins CP; Taylor JB; Sedgwick AD
    Br Vet J; 1987; 143(5):462-76. PubMed ID: 3119142
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor.
    Moore JN; Hardee MM; Hardee GE
    Am J Vet Res; 1986 Jan; 47(1):110-3. PubMed ID: 3080926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of ketoprofen and flunixin meglumine on the in vitro response of equine peripheral blood monocytes to bacterial endotoxin.
    Jackman BR; Moore JN; Barton MH; Morris DD
    Can J Vet Res; 1994 Apr; 58(2):138-43. PubMed ID: 8004539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats.
    Brideau C; Van Staden C; Chan CC
    Am J Vet Res; 2001 Nov; 62(11):1755-60. PubMed ID: 11703020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.